Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
STIP: Statin Trial for Influenza Patients
This study has been terminated.
( Inability to recruit participants since H1N1 epidemic resolved. )
Study NCT00970606 Information provided by Vanderbilt University
First Received on August 31, 2009. Last Updated on March 12, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Respiratory Distress Syndrome
Influenza
H1N1 Influenza
Additional conditions recognized in this trial
Acute Lung Injury
Influenza, Human
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
More general conditions related to this trial
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Orthomyxoviridae Infections
Respiration Disorders
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Rosuvastatin (crestor)
Placebo
Additional drug interventions recognized in this trial
Rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Gordon Bernard
Back to top of Main Content
